Market Cap 70.49M
Revenue (ttm) 80,000.00
Net Income (ttm) -31.93M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -39,912.50%
Debt to Equity Ratio 0.00
Volume 538,100
Avg Vol 59,380
Day's Range N/A - N/A
Shares Out 39.16M
Stochastic %K 76%
Beta 0.92
Analysts Strong Sell
Price Target $5.00

Company Profile

Sera Prognostics, Inc., a women's health company, discovers, develops, and commercializes blood-based biomarker tests, and predictive analytic products and services in the United States. The company develops the PreTRM test, a non-invasive blood test given to a pregnant woman, carrying a single fetus, during weeks 18 through 20 of gestation. It is also involved in the development of a pipeline of novel blood-based biomarker tests and predictive analytic products and services for pregnancy relate...

Industry: Medical Devices
Sector: Healthcare
Phone: 801 990 0520
Fax: 801 990 6601
Address:
2749 East Parleys Way, Suite 200, Salt Lake City, United States
WAYWARD_SUN
WAYWARD_SUN May. 23 at 1:12 AM
$SERA rocky hail mary
0 · Reply
topstockalerts
topstockalerts May. 23 at 1:08 AM
$SERA today’s quiet outperformer right here.
0 · Reply
SkullInferno
SkullInferno May. 22 at 11:03 PM
$SERA over 2,3 for more
0 · Reply
SkullInferno
SkullInferno May. 22 at 11:02 PM
$SERA Went on low voluem
0 · Reply
CH0WDER
CH0WDER May. 22 at 7:05 PM
$SERA push!!!!
0 · Reply
MilsLearning
MilsLearning May. 22 at 9:40 AM
0 · Reply
nevernevernevergoingdown
nevernevernevergoingdown May. 22 at 9:00 AM
$SERA potential news here
0 · Reply
Vale84
Vale84 May. 21 at 12:29 AM
0 · Reply
StocktwitsEarnings
StocktwitsEarnings May. 6 at 8:15 PM
$SERA Q1 '26 Earnings Results & Recap • Reported GAAP EPS of -$0.17 up 15.00% YoY • Reported revenue of $0.01M down -63.16% YoY • Sera Prognostics anticipates meaningful cost savings of approximately $9.6M in 2027, with decreased cash expenses of approximately 35% in R&D and 25% in G&A, expecting existing cash to fund operations through 2029.
0 · Reply
OfficialStocktwitsUser
OfficialStocktwitsUser Mar. 20 at 5:43 PM
$SERA RSI: 28.04, MACD: -0.2051 Vol: 0.19, MA20: 2.06, MA50: 2.62 ⚪ HOLD - Sideways 👉 https://quantumstockalerts.com Disclaimer: I am not a financial advisor. This post reflects personal analysis and opinions only. Please do your own research before investing or trading.
0 · Reply
Latest News on SERA
Sera Prognostics reports Q1 EPS (17c), consensus (17c)

2026-05-07T00:48:38.000Z - 16 days ago

Sera Prognostics reports Q1 EPS (17c), consensus (17c)


Sera Prognostics Earnings Call Transcript: Q1 2026

May 6, 2026, 5:00 PM EDT - 16 days ago

Sera Prognostics Earnings Call Transcript: Q1 2026


Sera Prognostics Earnings release: Q1 2026

May 6, 2026, 5:00 PM EDT - 16 days ago

Sera Prognostics Earnings release: Q1 2026


Sera Prognostics Quarterly report: Q1 2026

May 6, 2026, 5:00 PM EDT - 16 days ago

Sera Prognostics Quarterly report: Q1 2026


SERA PROGNOSTICS REPORTS FIRST QUARTER 2026 FINANCIAL RESULTS

May 6, 2026, 4:05 PM EDT - 16 days ago

SERA PROGNOSTICS REPORTS FIRST QUARTER 2026 FINANCIAL RESULTS


Sera Prognostics Slides: Corporate presentation

May 4, 2026, 7:00 AM EDT - 18 days ago

Sera Prognostics Slides: Corporate presentation


Sera Prognostics Proxy statement: Proxy filing

Apr 24, 2026, 8:00 AM EDT - 4 weeks ago

Sera Prognostics Proxy statement: Proxy filing


Sera Prognostics Proxy statement: Proxy filing

Apr 24, 2026, 8:00 AM EDT - 4 weeks ago

Sera Prognostics Proxy statement: Proxy filing


Sera Prognostics Slides: Corporate presentation

Apr 1, 2026, 3:30 AM EDT - 7 weeks ago

Sera Prognostics Slides: Corporate presentation


Sera Prognostics Earnings Call Transcript: Q4 2025

Mar 18, 2026, 5:00 PM EDT - 2 months ago

Sera Prognostics Earnings Call Transcript: Q4 2025


Sera Prognostics Annual report: Q4 2025

Mar 18, 2026, 5:00 PM EDT - 2 months ago

Sera Prognostics Annual report: Q4 2025


Sera Prognostics Earnings release: Q4 2025

Mar 18, 2026, 5:00 PM EDT - 2 months ago

Sera Prognostics Earnings release: Q4 2025


Sera Prognostics reports Q4 EPS (16c), consensus (19c)

2026-03-18T20:11:17.000Z - 2 months ago

Sera Prognostics reports Q4 EPS (16c), consensus (19c)


Sera Prognostics Slides: Corporate presentation

Mar 18, 2026, 7:00 AM EDT - 2 months ago

Sera Prognostics Slides: Corporate presentation


Sera Prognostics Slides: Corporate presentation

Feb 10, 2026, 7:00 AM EST - 3 months ago

Sera Prognostics Slides: Corporate presentation


Sera Prognostics initiated with a Buy at Jefferies

2025-12-14T17:35:07.000Z - 5 months ago

Sera Prognostics initiated with a Buy at Jefferies


Sera Announces Publication Acceptance for PRIME Study

Nov 24, 2025, 8:00 AM EST - 6 months ago

Sera Announces Publication Acceptance for PRIME Study


Sera Prognostics Earnings Call Transcript: Q3 2025

Nov 13, 2025, 5:00 PM EST - 6 months ago

Sera Prognostics Earnings Call Transcript: Q3 2025


Sera Prognostics Quarterly report: Q3 2025

Nov 13, 2025, 5:00 PM EST - 6 months ago

Sera Prognostics Quarterly report: Q3 2025


Sera Prognostics Earnings release: Q3 2025

Nov 13, 2025, 5:00 PM EST - 6 months ago

Sera Prognostics Earnings release: Q3 2025


SERA PROGNOSTICS REPORTS THIRD QUARTER 2025 FINANCIAL RESULTS

Nov 13, 2025, 4:05 PM EST - 6 months ago

SERA PROGNOSTICS REPORTS THIRD QUARTER 2025 FINANCIAL RESULTS


Sera Prognostics Names Dr. Tiffany Inglis Chief Medical Officer

Oct 1, 2025, 8:05 AM EDT - 8 months ago

Sera Prognostics Names Dr. Tiffany Inglis Chief Medical Officer


Sera Prognostics Earnings Call Transcript: Q2 2025

Aug 6, 2025, 5:00 PM EDT - 10 months ago

Sera Prognostics Earnings Call Transcript: Q2 2025


Sera Prognostics Quarterly report: Q2 2025

Aug 6, 2025, 5:00 PM EDT - 10 months ago

Sera Prognostics Quarterly report: Q2 2025


Sera Prognostics Earnings release: Q2 2025

Aug 6, 2025, 5:00 PM EDT - 10 months ago

Sera Prognostics Earnings release: Q2 2025


SERA PROGNOSTICS REPORTS SECOND QUARTER 2025 FINANCIAL RESULTS

Aug 6, 2025, 4:05 PM EDT - 10 months ago

SERA PROGNOSTICS REPORTS SECOND QUARTER 2025 FINANCIAL RESULTS


Sera Prognostics Slides: Corporate Presentation

Aug 6, 2025, 4:00 PM EDT - 10 months ago

Sera Prognostics Slides: Corporate Presentation


Sera Prognostics Earnings Call Transcript: Q1 2025

May 7, 2025, 5:00 PM EDT - 1 year ago

Sera Prognostics Earnings Call Transcript: Q1 2025


Sera Prognostics Quarterly report: Q1 2025

May 7, 2025, 5:00 PM EDT - 1 year ago

Sera Prognostics Quarterly report: Q1 2025


Sera Prognostics Earnings release: Q1 2025

May 7, 2025, 5:00 PM EDT - 1 year ago

Sera Prognostics Earnings release: Q1 2025


Sera Prognostics Proxy statement: Proxy Filing

Apr 23, 2025, 8:00 AM EDT - 1 year ago

Sera Prognostics Proxy statement: Proxy Filing


Sera Prognostics Proxy statement: Proxy Filing

Apr 23, 2025, 8:00 AM EDT - 1 year ago

Sera Prognostics Proxy statement: Proxy Filing


Sera Prognostics Earnings Call Transcript: Q4 2024

Mar 19, 2025, 5:00 PM EDT - 1 year ago

Sera Prognostics Earnings Call Transcript: Q4 2024


Sera Prognostics Annual report: Q4 2024

Mar 19, 2025, 5:00 PM EDT - 1 year ago

Sera Prognostics Annual report: Q4 2024


Sera Prognostics Earnings release: Q4 2024

Mar 19, 2025, 5:00 PM EDT - 1 year ago

Sera Prognostics Earnings release: Q4 2024


Sera Prognostics reports Q4 EPS (25c) vs. (25c) last year

2025-03-19T20:11:42.000Z - 1 year ago

Sera Prognostics reports Q4 EPS (25c) vs. (25c) last year


Sera Prognostics announces pricing of $50M public offering

2025-02-11T11:15:54.000Z - 1 year ago

Sera Prognostics announces pricing of $50M public offering


Sera Prognostics announces Class A common stock offering

2025-02-10T21:11:44.000Z - 1 year ago

Sera Prognostics announces Class A common stock offering


Sera Prognostics Announces Proposed Public Offering

Feb 10, 2025, 4:01 PM EST - 1 year ago

Sera Prognostics Announces Proposed Public Offering


Sera Prognostics Transcript: R&D Day 2025

Jan 31, 2025, 5:00 PM EST - 1 year ago

Sera Prognostics Transcript: R&D Day 2025


Sera Prognostics Slides: FY 2025

Jan 31, 2025, 5:00 PM EST - 1 year ago

Sera Prognostics Slides: FY 2025


Sera Prognostics to Host Virtual R&D Day on January 31

Jan 27, 2025, 5:02 PM EST - 1 year ago

Sera Prognostics to Host Virtual R&D Day on January 31


Sera Prognostics Slides: FY 2025

Jan 16, 2025, 12:45 PM EST - 1 year ago

Sera Prognostics Slides: FY 2025


Sera Prognostics Earnings Call Transcript: Q3 2024

Nov 6, 2024, 5:00 PM EST - 1 year ago

Sera Prognostics Earnings Call Transcript: Q3 2024


Sera Prognostics Quarterly report: Q3 2024

Nov 6, 2024, 5:00 PM EST - 1 year ago

Sera Prognostics Quarterly report: Q3 2024


Sera Prognostics Earnings release: Q3 2024

Nov 6, 2024, 5:00 PM EST - 1 year ago

Sera Prognostics Earnings release: Q3 2024


Sera Prognostics Transcript: UBS Genomic Medicine Conference

Aug 14, 2024, 11:00 AM EDT - 1 year ago

Sera Prognostics Transcript: UBS Genomic Medicine Conference


Sera Prognostics files $100M mixed securities shelf

2024-08-07T21:19:52.000Z - 1 year ago

Sera Prognostics files $100M mixed securities shelf


Sera Prognostics Earnings Call Transcript: Q2 2024

Aug 7, 2024, 5:00 PM EDT - 1 year ago

Sera Prognostics Earnings Call Transcript: Q2 2024


Sera Prognostics Quarterly report: Q2 2024

Aug 7, 2024, 5:00 PM EDT - 1 year ago

Sera Prognostics Quarterly report: Q2 2024


Sera Prognostics Earnings release: Q2 2024

Aug 7, 2024, 5:00 PM EDT - 1 year ago

Sera Prognostics Earnings release: Q2 2024


Sera Prognostics Registration statement: Registration Filing

Aug 7, 2024, 8:00 AM EDT - 1 year ago

Sera Prognostics Registration statement: Registration Filing


Sera Prognostics Inc trading resumes

2024-08-05T13:35:30.000Z - 1 year ago

Sera Prognostics Inc trading resumes


Sera Prognostics added to Russell 2000, Russell 3000 Indexes

2024-07-01T12:32:05.000Z - 2 years ago

Sera Prognostics added to Russell 2000, Russell 3000 Indexes


Sera Prognostics Earnings Call Transcript: Q1 2024

May 8, 2024, 5:00 PM EDT - 2 years ago

Sera Prognostics Earnings Call Transcript: Q1 2024


Sera Prognostics Quarterly report: Q1 2024

May 8, 2024, 5:00 PM EDT - 2 years ago

Sera Prognostics Quarterly report: Q1 2024


Sera Prognostics Earnings release: Q1 2024

May 8, 2024, 5:00 PM EDT - 2 years ago

Sera Prognostics Earnings release: Q1 2024


SERA PROGNOSTICS REPORTS FIRST QUARTER 2024 FINANCIAL RESULTS

May 8, 2024, 4:05 PM EDT - 2 years ago

SERA PROGNOSTICS REPORTS FIRST QUARTER 2024 FINANCIAL RESULTS


Sera Prognostics Proxy statement: Proxy Filing

Apr 23, 2024, 8:00 AM EDT - 2 years ago

Sera Prognostics Proxy statement: Proxy Filing


Sera Prognostics Proxy statement: Proxy Filing

Apr 23, 2024, 8:00 AM EDT - 2 years ago

Sera Prognostics Proxy statement: Proxy Filing


Sera Prognostics Earnings Call Transcript: Q4 2023

Mar 20, 2024, 5:00 PM EDT - 2 years ago

Sera Prognostics Earnings Call Transcript: Q4 2023


Sera Prognostics Annual report: Q4 2023

Mar 20, 2024, 5:00 PM EDT - 2 years ago

Sera Prognostics Annual report: Q4 2023


Sera Prognostics Earnings release: Q4 2023

Mar 20, 2024, 5:00 PM EDT - 2 years ago

Sera Prognostics Earnings release: Q4 2023


Sera Prognostics reports Q4 EPS (25c) vs. (31c) last year

2024-03-20T20:08:19.000Z - 2 years ago

Sera Prognostics reports Q4 EPS (25c) vs. (31c) last year


SERA PROGNOSTICS REPORTS FOURTH QUARTER 2023 FINANCIAL RESULTS

Mar 20, 2024, 4:05 PM EDT - 2 years ago

SERA PROGNOSTICS REPORTS FOURTH QUARTER 2023 FINANCIAL RESULTS


Sera Prognostics Earnings Call Transcript: Q3 2023

Nov 8, 2023, 5:00 PM EST - 2 years ago

Sera Prognostics Earnings Call Transcript: Q3 2023


Sera Prognostics Quarterly report: Q3 2023

Nov 8, 2023, 5:00 PM EST - 2 years ago

Sera Prognostics Quarterly report: Q3 2023


Sera Prognostics Earnings release: Q3 2023

Nov 8, 2023, 5:00 PM EST - 2 years ago

Sera Prognostics Earnings release: Q3 2023


SERA PROGNOSTICS REPORTS THIRD QUARTER 2023 FINANCIAL RESULTS

Nov 8, 2023, 4:05 PM EST - 2 years ago

SERA PROGNOSTICS REPORTS THIRD QUARTER 2023 FINANCIAL RESULTS


Sera Prognostics Earnings Call Transcript: Q2 2023

Aug 9, 2023, 5:00 PM EDT - 3 years ago

Sera Prognostics Earnings Call Transcript: Q2 2023


Sera Prognostics Quarterly report: Q2 2023

Aug 9, 2023, 5:00 PM EDT - 3 years ago

Sera Prognostics Quarterly report: Q2 2023


Sera Prognostics Earnings release: Q2 2023

Aug 9, 2023, 5:00 PM EDT - 3 years ago

Sera Prognostics Earnings release: Q2 2023


WAYWARD_SUN
WAYWARD_SUN May. 23 at 1:12 AM
$SERA rocky hail mary
0 · Reply
topstockalerts
topstockalerts May. 23 at 1:08 AM
$SERA today’s quiet outperformer right here.
0 · Reply
SkullInferno
SkullInferno May. 22 at 11:03 PM
$SERA over 2,3 for more
0 · Reply
SkullInferno
SkullInferno May. 22 at 11:02 PM
$SERA Went on low voluem
0 · Reply
CH0WDER
CH0WDER May. 22 at 7:05 PM
$SERA push!!!!
0 · Reply
MilsLearning
MilsLearning May. 22 at 9:40 AM
0 · Reply
nevernevernevergoingdown
nevernevernevergoingdown May. 22 at 9:00 AM
$SERA potential news here
0 · Reply
Vale84
Vale84 May. 21 at 12:29 AM
0 · Reply
StocktwitsEarnings
StocktwitsEarnings May. 6 at 8:15 PM
$SERA Q1 '26 Earnings Results & Recap • Reported GAAP EPS of -$0.17 up 15.00% YoY • Reported revenue of $0.01M down -63.16% YoY • Sera Prognostics anticipates meaningful cost savings of approximately $9.6M in 2027, with decreased cash expenses of approximately 35% in R&D and 25% in G&A, expecting existing cash to fund operations through 2029.
0 · Reply
OfficialStocktwitsUser
OfficialStocktwitsUser Mar. 20 at 5:43 PM
$SERA RSI: 28.04, MACD: -0.2051 Vol: 0.19, MA20: 2.06, MA50: 2.62 ⚪ HOLD - Sideways 👉 https://quantumstockalerts.com Disclaimer: I am not a financial advisor. This post reflects personal analysis and opinions only. Please do your own research before investing or trading.
0 · Reply
mikesterz7
mikesterz7 Mar. 18 at 8:23 PM
$SERA 🚨 In January 2026, the PRIME Study, a randomized controlled trial of 5,018 women, was published in PREGNANCY, the peer-reviewed journal of the Society for Maternal-Fetal Medicine. Key findings from the Study include: 56% and 32% fewer babies were born before 32 and 35 weeks, respectively 20% fewer babies admitted to the NICU Fewer health complications for newborns (20% reduction in odds of neonatal morbidity) A NICU day was saved for every 4.2 patients screened Advanced discussions underway with 10 commercial and Medicaid payers across 13 states for PreTRM program adoption, including the addition of a new partner program, bringing the total to two active partner programs. "2025 marked a pivotal year for Sera as we moved from clinical validation to commercial execution," said Zhenya Lindgardt, Sera's President and Chief Executive Officer.
0 · Reply
StocktwitsEarnings
StocktwitsEarnings Mar. 18 at 8:13 PM
$SERA Q4 '25 Earnings Results & Recap • Reported GAAP EPS of -$0.16 up 36.00% YoY • Reported revenue of $0.01M down -58.33% YoY • Sera Prognostics anticipates continued net losses and negative cash flows for the foreseeable future, but expects its cash runway to last through 2028. Research and development expenses are projected to decrease in 2026, while selling and marketing expenses are expected to increase.
0 · Reply
Fettenajs2026
Fettenajs2026 Mar. 18 at 6:11 PM
0 · Reply
topstockalerts
topstockalerts Mar. 13 at 1:17 PM
Pre Market Top Gainers PT2 $SERA $VEEE $ADTX $EEIQ $HKPD
0 · Reply
topstockalerts
topstockalerts Mar. 13 at 11:39 AM
Pre Market Top Gainers PT2 $SERA $VEEE $ADTX $EEIQ $HKPD
0 · Reply
prismmarketview
prismmarketview Mar. 11 at 4:45 PM
PRISM Mid-Day Movers: Beauty & Wellness and Pharmaceuticals are Today’s Leaders. The Beachbody Company (NASDAQ: $BODI) is jumping ~32% to $11 on quadruple‑normal volume as traders lean into its cost‑cut turnaround and higher‑margin digital fitness and nutrition subscriptions. KALA BIO (NASDAQ: $KALA) rips 28% to ~$0.38 on an eye‑popping 246M shares traded, a purely momentum‑driven bounce that still leaves this sub‑$10M, loss‑making biotech deep in penny‑stock territory. Other Notable Movers: Ocugen, Inc. ( $OCGN) up 26% Sera Prognostics ( $SERA) up 25% Wearable Devices Ltd. ( $WLDS) down -17% https://prismmarketview.com/prism-mid-day-movers-beauty-wellness-and-pharmaceuticals-are-todays-leaders/
0 · Reply
BillionerOfKing
BillionerOfKing Feb. 18 at 4:47 PM
$SERA Current Stock Price: $2.57 Contracts to trade: $2.5 SERA Feb 20 2026 Call Entry: $0.27 Exit: $0.41 ROI: 52% Hold ~28 days Shared as daily free alerts and for educational purposes only. https://dailypickai.com/freealerts
0 · Reply
OfficialStocktwitsUser
OfficialStocktwitsUser Jan. 25 at 1:20 AM
$SERA RSI: 56.78, MACD: 0.0441 Vol: 0.26, MA20: 3.37, MA50: 3.30 🟢 BUY - Uptrend + healthy RSI 👉 https://quantumstockalerts.com Disclaimer: I am not a financial advisor. This post reflects personal analysis and opinions only. Please do your own research before investing or trading.
0 · Reply
DARKP00L
DARKP00L Jan. 7 at 1:55 PM
$SERA 08:40 on Jan. 07 2026 Sera Prognostics Announces Randomized Trial Finds PreTRM Test Improves Outcomes By Identifying Women At Risk For Preterm Birth #tradeideas
0 · Reply
OfficialStocktwitsUser
OfficialStocktwitsUser Dec. 26 at 5:28 PM
$SERA RSI: 76.84, MACD: 0.1233 Vol: 0.24, MA20: 3.35, MA50: 3.26 🔴 SELL - Downtrend 👉 https://quantumstockalerts.com Disclaimer: I am not a financial advisor. This post reflects personal analysis and opinions only. Please do your own research before investing or trading.
0 · Reply
CalypsoCalls
CalypsoCalls Dec. 25 at 8:48 AM
$SERA Strategic positioning matters less than consistent throughput, because growth without leverage now attracts skepticism. Absent traction, patience will erode.
0 · Reply